Pennsylvania judge throws out lawsuit against generic drug companies

A federal judge on Monday dismissed a putative class action against generic drugmakers for causing the plaintiffs to overpay providers, ruling that the health insurance plan suing the companies could not have relied on the alleged misrepresentations because it was aware of the price inflation.

Unlock unlimited access to all Global Competition Review content